Cited by 405LGBTQ Health, Identity, and PolicyAdolescent and Pediatric HealthcareGender, Sexuality, and Education

Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation

Open access
Turban, Jack L., King, Dana, Carswell, Jeremi M., Keuroghlian, Alex S.·2020·Pediatrics

Abstract

BACKGROUND AND OBJECTIVES: Gonadotropin-releasing hormone analogues are commonly prescribed to suppress endogenous puberty for transgender adolescents. There are limited data regarding the mental health benefits of this treatment. Our objective for this study was to examine associations between access to pubertal suppression during adolescence and adult mental health outcomes. METHODS: Using a cross-sectional survey of 20 619 transgender adults aged 18 to 36 years, we examined self-reported history of pubertal suppression during adolescence. Using multivariable logistic regression, we examined associations between access to pubertal suppression and adult mental health outcomes, including multiple measures of suicidality. RESULTS: Of the sample, 16.9% reported that they ever wanted pubertal suppression as part of their gender-related care. Their mean age was 23.4 years, and 45.2% were assigned male sex at birth. Of them, 2.5% received pubertal suppression. After adjustment for demographic variables and level of family support for gender identity, those who received treatment with pubertal suppression, when compared with those who wanted pubertal suppression but did not receive it, had lower odds of lifetime suicidal ideation (adjusted odds ratio = 0.3; 95% confidence interval = 0.2–0.6). CONCLUSIONS: This is the first study in which associations between access to pubertal suppression and suicidality are examined. There is a significant inverse association between treatment with pubertal suppression during adolescence and lifetime suicidal ideation among transgender adults who ever wanted this treatment. These results align with past literature, suggesting that pubertal suppression for transgender adolescents who want this treatment is associated with favorable mental health outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1542/peds.2019-1725

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies have proven that anti-LGBTQ+ policies such as the denial of gender-affirming care are linked to higher rates of depression, suicidal ideation, and delayed healthcare.

    “Studies have proven that anti-LGBTQ+ policies such as the denial of gender-affirming care are linked to higher rates of depression, suicidal ideation, and delayed healthcare [51].”

    From Then, Now, Next: Unpacking the Shifting Trajectory of Social Determinants of Health (2025) · cites this paper as [51]

    The Results and Discussion report that, among transgender adults who wanted pubertal suppression, those who received it had lower odds of lifetime suicidal ideation than those who did not. The paper does not establish that anti-LGBTQ+ policies caused denial of care, nor does it link such policies or denial to higher depression rates or delayed healthcare. Its finding is an association, not proof of a causal effect. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 20

  1. [2]de Vries AL, Doreleijers TA, Steensma TD, Cohen-Kettenis PT. Psychiatric comorbidity in gender dysphoric adolescents. J Child Psychol Psychiatry. 2011; 52(11): 1195– 1202 21671938
  2. [3]Olson J, Schrager SM, Belzer M, Simons LK, Clark LF. Baseline physiologic and psychosocial characteristics of transgender youth seeking care for gender Dysphoria. J Adolesc Health. 2015; 57(4): 374– 380 26208863 PMC5033041
  3. [4]Spack NP, Edwards-Leeper L, Feldman HA, Children and adolescents with gender identity disorder referred to a pediatric medical center. Pediatrics. 2012; 129(3): 418– 425 22351896
  4. [5]Turban JL, Ehrensaft D. Research Review: gender identity in youth: treatment paradigms and controversies. J Child Psychol Psychiatry. 2018; 59(12): 1228– 1243 29071722
  5. [8]Coleman E, Bockting W, Botzer M, Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend 2012; 13(4): 165– 232
  6. [9]Lopez CM, Solomon D, Boulware SD, Christison-Lagay ER. Trends in the use of puberty blockers among transgender children in the United States. J Pediatr Endocrinol Metab 2018; 31(6): 665– 670 29715194
  7. [10]de Vries AL, Cohen-Kettenis PT. Clinical management of gender dysphoria in children and adolescents: the Dutch approach. J Homosex 2012; 59(3): 301– 320 22455322
  8. [11]de Vries AL, McGuire JK, Steensma TD, Wagenaar EC, Doreleijers TA, Cohen-Kettenis PT. Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics. 2014; 134(4): 696– 704 25201798
  9. [12]Costa R, Dunsford M, Skagerberg E, Holt V, Carmichael P, Colizzi M. Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria. J Sex Med 2015; 12(11): 2206– 2214 26556015
  10. [13]Herman-Giddens ME, Slora EJ, Wasserman RC, Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997; 99(4): 505– 512 9093289
  11. [14]Herman-Giddens ME, Steffes J, Harris D, Secondary sexual characteristics in boys: data from the Pediatric Research in Office Settings Network. Pediatrics. 2012; 130(5). Available at: www.pediatrics.org/cgi/content/full/130/5/e1058 23085608
  12. [16]Gilbert PA, Pass LE, Keuroghlian AS, Greenfield TK, Reisner SL. Alcohol research with transgender populations: a systematic review and recommendations to strengthen future studies. Drug Alcohol Depend 2018; 186: 138– 146 29571076 PMC5911250
  13. [17]Maxwell SE, Delaney HD. Bivariate median splits and spurious statistical significance. Psychol Bull 1993; 113(1): 181– 190
  14. [18]Stevens J, Gomez-Lobo V, Pine-Twaddell E. Insurance coverage of puberty blocker therapies for transgender youth. Pediatrics. 2015; 136(6): 1029– 1031 26527547
  15. [20]Meyer IH, Brown TN, Herman JL, Reisner SL, Bockting WO. Demographic characteristics and health status of transgender adults in select US regions: Behavioral Risk Factor Surveillance System, 2014. Am J Public Health. 2017; 107(4): 582– 589 28207334 PMC5343705
  16. [21]Beckwith N, Reisner SL, Zaslow S, Mayer KH, Keuroghlian AS. Factors associated with gender-affirming surgery and age of hormone therapy initiation among transgender adults. Transgend Health. 2017; 2(1): 156– 164 29159310 PMC5685205
  17. [22]Puckett JA, Cleary P, Rossman K, Newcomb ME, Mustanski B. Barriers to gender-affirming care for transgender and gender nonconforming individuals. Sex Res Social Policy. 2018; 15(1): 48– 59 29527241 PMC5842950
  18. [23]Rossom RC, Coleman KJ, Ahmedani BK, Suicidal ideation reported on the PHQ9 and risk of suicidal behavior across age groups. J Affect Disord 2017; 215: 77– 84 28319695 PMC5412508
  19. [24]Cai X, Hughto JMW, Reisner SL, Pachankis JE, Levy BR. Benefit of gender-affirming medical treatment for transgender elders: later-life alignment of mind and body. LGBT Health. 2019; 6(1): 34– 39 30562128 PMC6909671
  20. [25]Wiepjes CM, Nota NM, de Blok CJM, The Amsterdam cohort of gender dysphoria study (1972–2015): trends in prevalence, treatment, and regrets. J. Sex Med 2018; 15(4): 582– 590 29463477

Cited by

Sorted by citations

Authors
Turban, J. L., King, D., Carswell, J. M., & Keuroghlian, A. S.
Affiliations
  • Massachusetts General Hospital (US)
  • bThe Fenway Institute, Boston, Massachusetts; and
  • Boston Children's Hospital (US)
Corresponding author
Turban, Jack L.
Venue
Pediatrics
Published
2020-02-01
Volume
145
Issue
2
ISSN
  • 0031-4005 (ISSN-L)
  • 1098-4275
OpenAlex
W3001825536
Cited by
405
References
3
Citations by year
2026: 33 · 2025: 73 · 2024: 71 · 2023: 75 · 2022: 71 · 2021: 67 · 2020: 15
FWCI
62.31
Type
journal article
Language
en
Open access
Locations
  • PEDIATRICS (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Allergy and Infectious Diseases (UG3AI133669)
Topics
  • Social Sciences › Psychology › Social Psychology › LGBTQ Health, Identity, and Policy
  • Health Sciences › Health Professions › Speech and Hearing › Adolescent and Pediatric Healthcare
  • Social Sciences › Gender Studies › Gender, Sexuality, and Education
Keywords
puberty suppression, transgender youth, GnRH analogues, suicidal ideation, transgender adults, adolescent mental health, gender-affirming care
MeSH terms
Adolescent, Adult, Age Factors, Analysis of Variance, Cross-Sectional Studies, Female, Gender Identity, Health Services Accessibility, Humans, Gonadotropin-Releasing Hormone, Male, Mental Health, Puberty, Surveys and Questionnaires, Confidence Intervals, Odds Ratio, Young Adult, Suicidal Ideation, Transgender Persons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review